期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

新型载体聚己内酯对盐酸丁螺环酮缓释片释放的影响

Effects of Poly-ε-Caprolactone on Release of Buspirone Hydrochloride Sustained Tablets
下载PDF
导出
摘要 目的考察新型缓释载体材料聚己内酯对盐酸丁螺环酮缓释片中药物释放的影响。方法利用聚己内酯等为辅料,经湿法制粒制备盐酸丁螺环酮缓释片,并考察了不同相对分子质量和用量的聚己内酯对药物释放的影响。结果聚己内酯显示出良好的阻滞药物释放的性能,制备的缓释片能满足释放持续24h的设计用药要求。结论聚己内酯作为新型载体材料,适合于缓释片的阻滞剂。 OBJECTIVE To investigate the effects of poly-ε-caprolactone （PCL） on the release of buspirone sustained-tablets. METHODS The influence of different molecular weight and quantum of PCL in buspirone hydrochloride sustained-tablets prepared by wet granule compression method were studied. RESULTS As a novel exeipients, PCL exhibited satisfactory retarded effect, and compound was released for 24 h . CONCLUSION The novel excipient PCL is suitable to be used as retarder in tablets.
作者 蒋青锋 陈志良 陈建海 阎玺庆 杨莉 西娜
机构地区 南方医科大学附属南方医院药学部
出处 《中国药学杂志》 CAS CSCD 北大核心 2007年第2期125-128,共4页 Chinese Pharmaceutical Journal
基金 广东省科技计划项目(2002C30103)
关键词 聚己内酯 盐酸丁螺环酮 缓释片 poly-ε-caprolactone（PCL） buspirone hydrochloride sustained-tablets
分类号 R944.9 [医药卫生—药剂学]
  • 相关文献

参考文献7

  • 1KIM S Y,LEE Y M.Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(ε-caprolactone) as novel anticancer drug carriers[J].Biomaterials,2001,22:1697-1704.
  • 2JEONG J C,LEE J Y,CHO K.Effects of crystalline microstructure on drug release behaviour of poly (ε-caprolactone) microspheres[J].J Controlled Release,2003,92(3):249-258.
  • 3RYU J G,JEONG Y J,KIM S K,et al.Clonazepam release from core-shell type nanoparticles of poly(ε-caprolactone) / poly(ethylene glycol) / poly(ε-caprolactone) triblock copolymers[J].Int J Pharm,2000,20:231-242.
  • 4蒋青锋,陈建海,陈志良,阎玺庆,杨莉.控缓释制剂载体材料聚己内酯的制备及表征[J].华西药学杂志,2004,19(4):260-263. 被引量：12
  • 5蒋青锋,陈建海,陈志良,武金宝,阎玺庆,包杰.聚己内酯的细胞毒性和动物急性毒性实验[J].中国医院药学杂志,2005,25(9):798-800. 被引量：3
  • 6MAGHARLA D D,RAJADAS J R,CHANDRASEKAR V.Influence of manufacturing parameters on development of contraceptive steroid loaded injectable microspheres[J].Chem Pharm Bull,2004,52(8):976-979.
  • 7HOFFART V,UBRICH N,SIMONIN C,et al.Low molecular weight heparin-loaded polymeric nanopaticles:formation,characterization,and release characteristics[J].Drug Dev Ind Pharm,2002,28(9):1091-1099.

二级参考文献14

  • 1蒋青锋,陈建海,陈志良,阎玺庆,杨莉.控缓释制剂载体材料聚己内酯的制备及表征[J].华西药学杂志,2004,19(4):260-263. 被引量：12
  • 2Berrban M,Zahidi A. Preparation of poly-ε-caprolactone nanocapsules by nanoprecipitation and their evaluation using benzyl benzoate and GC-MS[J]. J Pharm Clin, 1999,18(4) :3132-3146.
  • 3Pitt CG. Polycaprolactone and its copolymers. In Larger R, and Chas in M Eds. Biodegradable polymers as drug delivery systems[M]. New York: Marcel Dekker, 1990. 70.
  • 4中华人民共和国国家标准GB／T．16886．12-1996.医疗器械生物学评价第12部分．样品制备与参照样品[s].[S].,..
  • 5Ferrari M, Fornasicro MC, Isseta AM. MTT Colorimetric assay for testing macrophage cytotoxic activity in vitro[J]. J Immunol Methods, 1990,13(2) : 165-172.
  • 6LiSM,Vert M.Biodegradation of aliphatic polyesters.In G Scott,D.Filead eds,Degradable polymers:Principles and applications[M].London:Chapman&Hall,1995.43
  • 7Song Y,Liu L,Weng X,et al.Acid-initiated polymerization of ep-silon-caprolactone under microwave irradiation and its application in the preparation of drug controlled release system[J].J Biomater Sci Polym Ed,2003,14(3):241
  • 8Pitt CG.Polycaprolactone and its copolymers.In Larger R,and Chas in M Eds.Biodegradable polymer as drug delivery systems[M].New York:Marcel Dekker,1990.70
  • 9Christine Allen,Jeannie Han,Yu Yisong,et al.Polycaprolactone-b-poly(ethylene oxide)copolymer micelles ad a delivery vehicle for dihy-drotestosterone[J].Journal of Controlled Release,2000,63:275
  • 10Jin Woo Lee,Feng jun-hua,Doo Sung Lee.Thermoreversible gela-tion of biodegradable Poly(ε-caprolactone)and poly(ethylene gly-col)mutiblock copolymers in aqueous solutions[J].Journal of Con-trolled Release,2001,73:315

共引文献13

中国药学杂志
2007年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部